Journal Logo

Secondary Logo
 

May/June 2018 - Volume 12 - Issue 3

  • Richard Saitz, MD, MPH, DFASAM, FACP
  • 1932-0620
  • 1935-3227
  • 6 issues / year
  • 11/19
  • 2.406

Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines

Lintzeris, Nicholas; Monds, Lauren A.; Rivas, Consuelo; More

Journal of Addiction Medicine. 12(3):234-240, May/June 2018.

Read the article about the new National Practice Guideline from the American Society of Addiction Medicine on the Use of Medication in the Treatment of Addiction Involving Opioid Use from the American Society of Addiction Medicine. Read the article about the Guideline here.

Today, marks an historic day as ASAM convened stakeholders, including several medical societies, eight federal agencies, patient and payers organizations at the National Press Club in Washington, DC, for a press conference and stakeholder summit to announce and accelerate the adoption of its newly released National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use (National Practice Guideline) and associated products. The meeting … Read more about the conference here.

National Addiction Treatment Week Announced

04/19/2018

The American Society of Addiction Medicine (ASAM) will be hosting National Addiction Treatment Week, April 23rd through April 29th, raises awareness that addict...

ACA and ASAM Release Joint Policy Statement on Opioid Use Disorder Treatment in the Justice System

03/20/2018

The statement includes recommendations to support correctional policy makers and correctional healthcare professionals in providing evidence-based care to those...

ASAM Response to Administration Initiative

03/19/2018

ASAM stands ready to be part of what should, and must be, a nationwide effort to prevent deaths and engage people in treatment, while we lay the groundwork for ...

ASAM Applauds SAMHSA in Releasing New Treatment Improvement Protocol (TIP) 63

03/01/2018

SAMHSA’s TIP 63 reviews the use of the three FDA-approved medications used to treat opioid addiction—methadone, naltrexone, and buprenorphine—and other strategi...

ASAM Applauds Walmart’s Launch of DisposeRx

01/24/2018

Nearly 11 million people misused prescription pain relievers in 2016.[i] ASAM applauds Walmart’s actions to combat the opioid epidemic and we hope the debut of ...

The ASAM Review Course in Addiction Medicine
July 27th - July 29th - The course offers two and a half days of sessions which are mapped to the addiction medicine exam blueprint of topics for the board exam and features an outstanding faculty.
Click here for more information.

The ASAM Treatment of Opioid of Opioid Use Disorder Course
Online/Live - Includes waiver qualifying requirements for authority to prescribe buprenorphine for the treatment of opioid dependence. This course covers medications to manage patients with addiction involving opioid use. Click here for more information.

Publishing Addiction Science
Online - This FREE online course includes editors from the Journal of Addiction Medicine who will de-mystify the publication process and provide knowledge and skills for publishing addiction science. Click here for more information.